SAFFRON Data Reveal New Global SOC in EGFR+ NSCLC with MET Overexpression and/or Amplification After Osimertinib

Sunvozertinib Now Available in the US for Previously Treated EGFR Exon 20 Insertion–Mutated NSCLC

October 29, 2026

Enozertinib Elicits Responses in Treatment-Naive NSCLC with Atypical EGFR Mutations

October 29, 2026

Iza-Bren Improves PFS vs Platinum Chemo in EGFR-Mutated NSCLC After Third-Generation TKI

October 27, 2026

Savolitinib Combo Extends PFS in Frontline EGFR-Mutated NSCLC and MET Overexpression

October 27, 2026